PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 111 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $189,000 | -33.9% | 63,800 | +0.3% | 0.00% | – |
| Q4 2021 | $286,000 | -7.4% | 63,600 | 0.0% | 0.00% | – |
| Q3 2021 | $309,000 | -28.8% | 63,600 | 0.0% | 0.00% | – |
| Q2 2021 | $434,000 | +14.2% | 63,600 | +18.2% | 0.00% | – |
| Q1 2021 | $380,000 | +4.4% | 53,800 | -7.6% | 0.00% | – |
| Q4 2020 | $364,000 | +8.7% | 58,200 | -6.1% | 0.00% | – |
| Q3 2020 | $335,000 | +3.4% | 62,000 | 0.0% | 0.00% | – |
| Q2 2020 | $324,000 | +82.0% | 62,000 | +9.9% | 0.00% | – |
| Q1 2020 | $178,000 | -4.8% | 56,400 | +21.8% | 0.00% | – |
| Q4 2019 | $187,000 | -6.5% | 46,300 | 0.0% | 0.00% | – |
| Q3 2019 | $200,000 | +8.1% | 46,300 | 0.0% | 0.00% | – |
| Q2 2019 | $185,000 | -21.9% | 46,300 | +4.8% | 0.00% | – |
| Q1 2019 | $237,000 | 0.0% | 44,200 | -4.3% | 0.00% | – |
| Q4 2018 | $237,000 | -44.8% | 46,200 | +4.5% | 0.00% | – |
| Q3 2018 | $429,000 | -4.9% | 44,200 | 0.0% | 0.00% | – |
| Q2 2018 | $451,000 | +2.7% | 44,200 | +30.8% | 0.00% | – |
| Q1 2018 | $439,000 | -7.8% | 33,800 | +27.1% | 0.00% | – |
| Q4 2017 | $476,000 | -28.7% | 26,600 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $668,000 | +32.5% | 26,600 | +27.3% | 0.00% | – |
| Q2 2017 | $504,000 | +114.5% | 20,900 | +71.3% | 0.00% | – |
| Q1 2017 | $235,000 | +25.0% | 12,200 | 0.0% | 0.00% | – |
| Q4 2016 | $188,000 | +32.4% | 12,200 | +11.9% | 0.00% | – |
| Q3 2016 | $142,000 | – | 10,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|